|1.||Kaneda, K: 3 articles (02/2014 - 03/2002)|
|2.||Saitoh, Yuhji: 3 articles (01/2008 - 01/2005)|
|3.||Oshima, Tsutomu: 3 articles (01/2008 - 08/2006)|
|4.||Itoh, H: 3 articles (12/2004 - 09/2001)|
|5.||Murakawa, M: 3 articles (08/2004 - 03/2002)|
|6.||Saitoh, Y: 3 articles (08/2004 - 03/2002)|
|7.||Nakajima, H: 3 articles (08/2004 - 01/2001)|
|8.||Menigaux, C: 3 articles (12/2002 - 01/2000)|
|9.||Chauvin, M: 3 articles (12/2002 - 01/2000)|
|10.||Guignard, B: 3 articles (12/2002 - 01/2000)|
12/01/2011 - "Intermittent boluses of vecuronium were more effective in reaching a goal TOF response earlier compared with continuous-infusion vecuronium in patients treated with therapeutic hypothermia. "
11/22/2011 - "To study the relationship between the intraoperative hypothermia and the residual neuromuscular of single intubation dose of vecuronium. "
12/01/1994 - "The purpose of this study was to determine the extent to which localized hypothermia of a monitored extremity alters the assessment of recovery from vecuronium-induced neuromuscular blockade. "
12/01/2011 - "Of 123 adults treated with therapeutic hypothermia after SCA, 80 received continuous-infusion vecuronium 0.8 μg/kg/minute started 2 hours after cooling began or if shivering occurred (January 1, 2004-December 31, 2007), and 43 received intermittent boluses of vecuronium 0.05 mg/kg every 2 hours (January 1, 2008-September 30, 2009). "
11/22/2011 - "[The relationship between the intraoperative hypothermia and the residual neuromuscular of single intubation dose of vecuronium]."
01/01/2014 - "This study aims to investigate the effects of sepsis on the neuromuscular block properties of vecuronium in relation to the expression of fetal and neuronal α7 type nAChR. "
01/01/2014 - "The half maximal inhibitory response of vecuronium in the sepsis group significantly increased, peaked on Day 7, and then declined on Day 14 (P<0.05). "
10/01/1999 - "In sepsis/placebo rats, vecuronium-induced neuromuscular blockade was prolonged (144% of contro/placebo), vecuronium plasma levels at 50% neuromuscular blockade were increased (122% of control/placebo), and plasma clearance was decreased (68% of control/placebo). "
10/01/1990 - "Vecuronium and sepsis."
01/01/2014 - "Pharmacodynamic changes with vecuronium in sepsis are associated with expression of α7- and γ-nicotinic acetylcholine receptor in an experimental rat model of neuromyopathy."
11/01/1997 - "This study presents an artificial neural network-based controller for regulating the level of induced paralysis during surgery using vecuronium bromide. "
09/01/1997 - "This study models the effect compartment concentrations associated with vecuronium-induced paralysis, combining them explicitly with the range of concentrations associated with the TOF count to demonstrate the kinetic mechanisms underlying the time-course of paralysis."
04/01/1995 - "This study demonstrated that the rapidity of the onset of paralysis in the adductor pollicis muscle after vecuronium injection into a peripheral vein is clearly related to cardiac output."
04/01/2015 - "After vecuronium infusion, the infant developed an irreversible postoperative paralysis, leading to death 32 days after surgery. "
08/01/2006 - "[Prolonged paralysis after long-term administration of vecuronium in the intensive care unit]."
|4.||Chronic Kidney Failure (Chronic Renal Failure)
01/01/2012 - "One hundred chronic renal failure patients were assigned into four groups according to the used vecuronium priming regimen. "
01/01/2012 - "The pharmacodynamics of vecuronium in chronic renal failure patients: the impact of different priming doses."
05/01/2001 - "Duration of action of vecuronium is prolonged in patients with end-stage renal failure mainly due to higher sensitivity to vecuronium."
05/01/2001 - "To determine whether the duration of action of vecuronium is influenced by chronic renal failure. "
05/01/2001 - "Increased sensitivity to vecuronium and prolonged duration of its action in patients with end-stage renal failure."
|5.||Renal Insufficiency (Renal Failure)
10/01/1981 - "Estimates of distribution half-life (T 1/2 alpha), elimination half-life (T 1/2 beta), volume of distribution at steady state (Vss) and clearance of Org NC 45 did not differ significantly between patients with normal renal function and those with renal failure. "
08/01/1993 - "Eight trials comparing the effects of vecuronium in patients with either normal renal function or renal failure were subjected to a meta-analysis. "
08/01/2006 - "We believe that the cause is the accumulation of vecuronium and active metabolites due to renal failure. "
11/01/1997 - "In 15 adult patients receiving haemodialysis for renal failure the onset of vecuronium-induced neuromuscular blockade after 0.08 mg-kg-1 vecuronium i.v. was measured. "
08/01/1993 - "Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis."
|1.||Neostigmine (Neostigmine Bromide)
|3.||rocuronium (rocuronium bromide)
|6.||Glycopyrrolate (Glycopyrronium Bromide)
|10.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|3.||Artificial Respiration (Mechanical Ventilation)